Literature DB >> 23680888

Recent advances in the epidemiology, outcome, and prevention of myocardial infarction and stroke in sub-Saharan Africa.

Mpiko Ntsekhe1, Albertino Damasceno.   

Abstract

The early part of the new millennium witnessed reports of a growing burden of cardiovascular disease in Sub-Saharan Africa (SSA). However the contribution of ischemic heart disease and stroke to this increasing burden relative to that caused by hypertensive heart disease, cardiomyopathy and rheumatic heart disease was not clear. Over the last decade, data from the continent has begun to clarify this issue and suggests three main points. The burden of ischemic heart disease relative to other causes of heart disease remains low particularly in the black Africans majority. Stroke caused predominantly by hypertension is now a major cause of disability and premature death. Third, the burden of risk factors for atherosclerosis is increasing rapidly in most urban and some rural regions. A concerted effort to understand the primary drivers of this increase in cardiac risk factors is required to prevent a future epidemic of atherosclerosis and its sequelae.

Entities:  

Keywords:  CORONARY ARTERY DISEASE

Mesh:

Year:  2013        PMID: 23680888     DOI: 10.1136/heartjnl-2012-303585

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  19 in total

1.  Vitamin D and Atherosclerotic Cardiovascular Disease.

Authors:  Thomas Hiemstra; Kenneth Lim; Ravi Thadhani; JoAnn E Manson
Journal:  J Clin Endocrinol Metab       Date:  2019-04-04       Impact factor: 5.958

2.  The Demography of Mental Health Among Mature Adults in a Low-Income, High-HIV-Prevalence Context.

Authors:  Iliana V Kohler; Collin F Payne; Chiwoza Bandawe; Hans-Peter Kohler
Journal:  Demography       Date:  2017-08

3.  Hypertension, cardiovascular risk factors and antihypertensive medication utilisation among HIV-infected individuals in Rakai, Uganda.

Authors:  Laura D Sander; Kevin Newell; Paschal Ssebbowa; David Serwadda; Thomas C Quinn; Ronald H Gray; Maria J Wawer; George Mondo; Steven Reynolds
Journal:  Trop Med Int Health       Date:  2014-12-26       Impact factor: 2.622

4.  The epidemiology of cardiovascular diseases in sub-Saharan Africa: the Global Burden of Diseases, Injuries and Risk Factors 2010 Study.

Authors:  Andrew Moran; Mohammad Forouzanfar; Uchechukwu Sampson; Sumeet Chugh; Valery Feigin; George Mensah
Journal:  Prog Cardiovasc Dis       Date:  2013-09-28       Impact factor: 8.194

5.  Towards developing guidelines and systems of care to facilitate early reperfusion for ST-elevation myocardial infarction in Africa.

Authors:  Rhena Delport
Journal:  Cardiovasc J Afr       Date:  2014 Nov-Dec       Impact factor: 1.167

6.  High prevalence and clustering of modifiable CVD risk factors among rural adolescents in southwest Nigeria: implication for grass root prevention.

Authors:  N A Odunaiya; K Grimmer; Q A Louw
Journal:  BMC Public Health       Date:  2015-07-14       Impact factor: 3.295

Review 7.  Cardiovascular disease risk amongst African black patients with rheumatoid arthritis: the need for population specific stratification.

Authors:  Ahmed Solomon; Linda Tsang; Angela J Woodiwiss; Aletta M E Millen; Gavin R Norton; Patrick H Dessein
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

8.  Modelling the potential impact of a sugar-sweetened beverage tax on stroke mortality, costs and health-adjusted life years in South Africa.

Authors:  Mercy Manyema; Lennert J Veerman; Aviva Tugendhaft; Demetre Labadarios; Karen J Hofman
Journal:  BMC Public Health       Date:  2016-05-31       Impact factor: 3.295

9.  The Pan-African Society of Cardiology (PASCAR) in 2013 and beyond.

Authors:  Anastase Dzudie; Bongani M Mayosi
Journal:  Cardiovasc J Afr       Date:  2013-06       Impact factor: 1.167

10.  A snapshot of cardiovascular diseases in Africa in the new millennium.

Authors:  A P Kengne; B M Mayosi
Journal:  Cardiovasc J Afr       Date:  2013-05       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.